New Approaches to the Management of Peripheral Vertigo: Efficacy and Safety of Two Calcium Antagonists in a 12-week, Multinational, Double-Blind Study

@article{Pianese2002NewAT,
  title={New Approaches to the Management of Peripheral Vertigo: Efficacy and Safety of Two Calcium Antagonists in a 12-week, Multinational, Double-Blind Study},
  author={Carlo Pane Pianese and Lourdes Olivia Vales Hidalgo and Ram{\'o}n Hinojosa Gonz{\'a}lez and Cecilia Esteinou Madrid and Jorge Enrique Cruz Ponce and Alberto Ma{\~n}{\'e} Ram{\'i}rez and Luis Moran and Jos{\'e} Enrique Po{\'o} Arenas and Arturo Torres‐Y Guti{\'e}rrez Rubio and Jorge Uribe and Jos{\'e} Abiuso and Enrique Hanuch and Juan Carlos {\'A}vila Alegr{\'i}a and Claudio Volpi and Renate Flaskamp and A Sanjuan and Juan Manuel Garc{\'i}a G{\'o}mez and Jaime Hern{\'a}ndez and Alvaro Arias Pedraza and Diana Quijano and Carolina Mart{\'i}nez and J Casta{\~n}eda and {\'O}scar Guerra and G Valencia F},
  journal={Otology \& Neurotology},
  year={2002},
  volume={23},
  pages={357-363}
}
Objective To evaluate the efficacy and safety profile of one 30-mg nimodipine oral tablet taken three times per day (one tablet with breakfast, one with lunch, and one with dinner) or one 150-mg cinnarizine verum oral capsule taken once each day with dinner for 12 weeks. Study Design Comparative in a double-blind, multinational pilot study. Setting Tertiary referral center. Patients A total of 221 patients met the study criteria; of that total, 181 adult patients completed the study, including… 
Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate
TLDR
The results suggest that CIN is an effective and safe prophylactic agent even in severe migraine headache.
Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience
  • D. MonzaniM. Barillari E. Genovese
  • Medicine
    Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale
  • 2012
TLDR
It was concluded that nimodipine represents not only a valid add-therapy for Ménière's disease, and that it may also exert a specific effect on inner ear disorders.
Cinnarizine/betahistine combination vs. the respective monotherapies in acute peripheral vertigo: a randomized triple-blind placebo-controlled trial
TLDR
This study indicated the superiority of the cinnarizine/betahistine combination over the respective monotherapies in the treatment of APV.
Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: an open, randomized comparative trial with propranolol
TLDR
In this open study, cinnarizine appeared as effective as propranolol and safe for the prophylaxis of migraine in children, but this remains to be confirmed in a double-blind placebo-controlled trial.
Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study
TLDR
The data do not differ from those of previous works assessing efficacy of different prophylactic therapies for VM and reporting consistent reduction of vertigo spells in a rate of patients ranging from 60 and 80 %.
Cinnarizine as an alternative recommendation for migraine prophylaxis: a narrative review
TLDR
The evidence shows that cinnarizine’s effectiveness was more promising in pediatric migraineurs and adults with migraine-associated vertigo such as vestibular migraine, and before reaching a definite conclusion on its effectiveness, it is necessary to do further high-quality RCTs among both children and adults.
Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study
TLDR
This study suggests that cinnarizine is safe and effective in reducing both headache and vertigo aspects of “migraine plus vertigo” among the patients who suffer from either vestibular migraine or migraine with brainstem aura associated with vertigo.
Management of peripheral vertigo with antihistamines: New options on the horizon
TLDR
Encouraging outcomes in an induced vertigo model in healthy volunteers have led to ongoing clinical studies in acute unilateral vestibulopathy, with the hope that H4 antagonists will offer new effective therapeutic options to patients suffering from vertigo.
Pharmacological Treatment of Vertigo
This review discusses the physiology and pharmacological treatment of vertigo and related disorders. Classes of medications useful in the treatment of vertigo include anticholinergics,
The Comparison of Ginkgo biloba and Cinnarizine effectiveness in tinnitus intensity of patients with subjective tinnitus
TLDR
It was found that after two months of treatment with Ginkgo biloba (120-140 mg daily) tinnitus severity and the adverse changes on quality of life significantly decreased in the patients, whereas Cinnarizine did not reduce the latter significantly.
...
...

References

SHOWING 1-10 OF 19 REFERENCES
Use of nimodipine in the medical treatment of Menière's disease: clinical experience.
TLDR
Nimodipine provides an alternative successful means for medical management of Meniere's disease and was discontinued in one class D patient because of gastrointestinal intolerance.
Use of nimodipine in the medical treatment of Menière's disease: clinical experience.
TLDR
Nimodipine provides an alternative successful means for medical management of Menière's disease and was discontinued in one class D patient because of gastrointestinal intolerance.
Calcium Entry Blockers in the Treatment of Vertigo
  • J. Olesen
  • Psychology
    Annals of the New York Academy of Sciences
  • 1988
TLDR
A number of studies dealing with vertigo of central etiology were positive and the level of proof for flunarizine is still as good as for other substances or better, whether the effects are due to calcium entry blocking properties.
Flunarizine in the treatment of vertigo
TLDR
Open therapeutic findings showed that flunarizine is of benefit to patients with vertigo of labyrinthine as well as of cerebrovascular origin, and results were confirmed in double-blind controlled trials.
Antivertigo medications and drug-induced vertigo. A pharmacological review.
TLDR
It is hoped that new treatments may emerge from the present interest in receptor subclasses and neuromodulators of the vestibular system, and the authors must be ready to evaluate these potential new pharmacological agents with reliable clinical methods in humans.
Calcium antagonists in migraine and vertigo. Possible mechanisms of action and review of clinical trials.
  • J. Olesen
  • Medicine, Psychology
    European neurology
  • 1990
Three primary mechanisms have been suggested as an explanation of migraine; a neuronal event, a vascular event and a mechanism focussing on the trigeminal nerve and its supply to intra- and
[Calcium blockers in the therapy of vertebrobasilar insufficiency. Results of animal experiments and clinical studies].
TLDR
Patient tests as well as animal experiments showed, that flunarizine and nimodipine have a depressant influence on the pathologically increased nystagmus frequency and with both substances there was also a trend to normalization of nyStagmus amplitude.
Pharmacological improvement of vestibular plasticity. Effects of a Ca2+-antagonist agent.
Ultrasonographic study of normal and pathological hemodynamics in the arterial vertebro-basilar system.
  • C. ŞipoşH. SalcaV. Popa
  • Chemistry
    Romanian journal of neurology and psychiatry = Revue roumaine de neurologie et psychiatrie
  • 1994
TLDR
The velocimetric complexes of vertebral arteries were studied and it seems that MDV related to PSV is more indicated than EDV to appreciate cerebrovascular resistance.
Medial vestibular nucleus in the guinea-pig
TLDR
Intracellular recordings were obtained from medial vestibular nuclei neurones (MVNn) in guinea-pig brainstem slices from two main distinct neuronal classes, characterized by a broad action potential followed by a deep single afterhyperpolarization, a transient A-like rectification, and a single range of firing in response to current injection.
...
...